Literature DB >> 6326671

Can biological calcification occur in the presence of pyrophosphate?

J L Meyer.   

Abstract

It was shown that it is apparently impossible for any calcification to occur in a system which contains a constant, physiological concentration of inorganic pyrophosphate. These results give further support to the earlier suggestion that inhibitors of calcium phosphate crystal growth must be removed from or denied access to the site of calcification to allow for the normal formation of the mineral phase. This study also suggests that the means of assessing the relative importance of a calcification inhibitor should be altered, since it is the equilibrium concentration of an inhibitor, and not its initial concentration in an assay system, which has physiological relevance.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6326671     DOI: 10.1016/0003-9861(84)90356-4

Source DB:  PubMed          Journal:  Arch Biochem Biophys        ISSN: 0003-9861            Impact factor:   4.013


  67 in total

1.  Extracellular pyrophosphate metabolism and calcification in vascular smooth muscle.

Authors:  Ricardo Villa-Bellosta; Xiaonan Wang; José Luis Millán; George R Dubyak; W Charles O'Neill
Journal:  Am J Physiol Heart Circ Physiol       Date:  2011-04-13       Impact factor: 4.733

Review 2.  Selective drug delivery to bone using acidic oligopeptides.

Authors:  Junko Ishizaki; Yoshihiro Waki; Tatsuo Takahashi-Nishioka; Koichi Yokogawa; Ken-Ichi Miyamoto
Journal:  J Bone Miner Metab       Date:  2008-11-19       Impact factor: 2.626

3.  Identification of novel regulators of osteoblast matrix mineralization by time series transcriptional profiling.

Authors:  Katherine Ann Staines; Dongxing Zhu; Colin Farquharson; Vicky Elizabeth MacRae
Journal:  J Bone Miner Metab       Date:  2013-08-08       Impact factor: 2.626

4.  Structural studies of human alkaline phosphatase in complex with strontium: implication for its secondary effect in bones.

Authors:  Paola Llinas; Michel Masella; Torgny Stigbrand; André Ménez; Enrico A Stura; Marie Hélène Le Du
Journal:  Protein Sci       Date:  2006-07       Impact factor: 6.725

5.  Matrix Gla protein metabolism in vascular smooth muscle and role in uremic vascular calcification.

Authors:  Koba A Lomashvili; Xiaonan Wang; Reidar Wallin; W Charles O'Neill
Journal:  J Biol Chem       Date:  2011-06-24       Impact factor: 5.157

6.  Hypophosphatasia - pathophysiology and treatment.

Authors:  José Luis Millán; Horacio Plotkin
Journal:  Actual osteol       Date:  2012-09-01

7.  Acute and 3-month effects of calcium carbonate on the calcification propensity of serum and regulators of vascular calcification: secondary analysis of a randomized controlled trial.

Authors:  S M Bristow; G D Gamble; A Pasch; W C O'Neill; A Stewart; A M Horne; I R Reid
Journal:  Osteoporos Int       Date:  2015-10-22       Impact factor: 4.507

8.  Inhibition of PHOSPHO1 activity results in impaired skeletal mineralization during limb development of the chick.

Authors:  Vicky E Macrae; Megan G Davey; Lynn McTeir; Sonoko Narisawa; Manisha C Yadav; Jose Luis Millan; Colin Farquharson
Journal:  Bone       Date:  2010-01-04       Impact factor: 4.398

9.  Upregulation of alkaline phosphatase and pyrophosphate hydrolysis: potential mechanism for uremic vascular calcification.

Authors:  K A Lomashvili; P Garg; S Narisawa; J L Millan; W C O'Neill
Journal:  Kidney Int       Date:  2008-02-20       Impact factor: 10.612

10.  Proteoliposomes harboring alkaline phosphatase and nucleotide pyrophosphatase as matrix vesicle biomimetics.

Authors:  Ana Maria S Simão; Manisha C Yadav; Sonoko Narisawa; Mayte Bolean; Joao Martins Pizauro; Marc F Hoylaerts; Pietro Ciancaglini; José Luis Millán
Journal:  J Biol Chem       Date:  2010-01-04       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.